Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.
Nathan RA, Bernstein JA, Bielory L, Bonuccelli CM, Calhoun WJ, Galant SP, Hanby LA, Kemp JP, Kylstra JW, Nayak AS, O'Connor JP, Schwartz HJ, Southern DL, Spector SL, Williams PV.
Nathan RA, et al. Among authors: spector sl.
J Allergy Clin Immunol. 1998 Dec;102(6 Pt 1):935-42. doi: 10.1016/s0091-6749(98)70331-8.
J Allergy Clin Immunol. 1998.
PMID: 9847434
Clinical Trial.